Dr. Harry C. Dietz, professor in the Institute for Genetic Medicine at Johns Hopkins University School of Medicine (Baltimore, USA), has been awarded with the "http://www.inbevbailletlatour.com/index.cfm?ee=3|316" InBev-Baillet Latour Health Prize, one of the most important international scientific prizes after the Nobel Prize. Dr. David García-Dorado, head of the Cardiovascular Diseases group at Vall d’Hebron Institute of Research (VHIR) and Chief of the Cardiology Department at Vall d’Hebron University Hospital, presented the award, as the Chairman of the jury, in the ceremony hosted the April 23 in Brussels (Belgium) and presided by the Princess Matilde.Dr. Dietz is honored for his fundamental contributions to the genetics, pathobiology and medical treatment of Marfan syndrome, aneurysms and other vascular disorders. His work offers new hope for improving the medical treatment of a great number of patients. The InBev-Baillet Latour Fund was established to promote outstanding achievements in the area of science, academy or art. The Health Prize, worth € 250,000, is intended to promote not only fundamental research, but also its applications to human health.